Spero Therapeutics
SPRO
#9628
Rank
โ‚น3.43 B
Marketcap
โ‚น61.41
Share price
-0.98%
Change (1 day)
-48.79%
Change (1 year)

Spero Therapeutics (SPRO) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น5.49 Billion

According to Spero Therapeutics's latest financial reports the company's total liabilities are โ‚น5.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Spero Therapeutics - Total liabilities on balance sheet (from 2016 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น6.28 B55.42%
2022-12-31โ‚น4.04 B-34.37%
2021-12-31โ‚น6.16 B293.5%
2020-12-31โ‚น1.56 B-30.36%
2019-12-31โ‚น2.24 B144.51%
2018-12-31โ‚น0.91 B68.99%
2017-12-31โ‚น0.54 B8.05%
2016-12-31โ‚น0.50 B1.95%
2015-12-31โ‚น0.49 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น13.58 B 147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.363 T 170,316.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น548.53 B 9,882.92%๐Ÿ‡จ๐Ÿ‡ฆ Canada